A critical role for transforming growth factor-β in donor transfusion- induced allograft tolerance

Journal of Clinical Investigation

Volumn 102, Issue 11, 1998, Pages 1920-1926

  Josien, Régis ^a   Douillard, Patrice ^a,c   Guillot, Cécile ^a   Müschen, Markus ^b   Anegon, Ignacio ^a   Chetritt, Jérôme ^a   Menoret, Séverine ^a   Vignes, Caroline ^a   Soulillou, Jean Paul ^a   Cuturi, Maria Cristina ^a  

^a INSERM   (France)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Rodent; Suppression; TGF ; Tolerance; Transplantation

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 0032436036     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4221     Document Type: Article

References (12)

1. Palladino, M., R. Morris, H. Fletcher Starnes, and A. Levinson. 1991. The transforming growth factor-betas. A new family of immunomodulatory molecules. Ann. NY Acad. Sci. 593:181-187.
2. Wahl, S., N. McCartney-Francis, and S. Mergenhagen. 1989. Inflammatory and immunomodulatory roles of TGFβ. Immunol. Today. 10:258-261.
3. Brabletz, T., I. Pfeuffer, E. Shorr, F. Siebelt, T. Wirth, and E. Serfling. 1993. Transforming growth factor β and cyclosporine A inhibits the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol. Cell. Biol. 13:1155-1162.
4. Kehrl, J., L. Wakefield, A. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. Sporn, and A. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.
5. Ahuja, S., F. Paliogianni, H. Yamada, J. Balow, and D. Boumpas. 1993. Effect of transforming growth factor-β on early and late activation events in human T cells. J. Immunol. 150:3109-3118.
6. Kehrl, J.H., A.S. Taylor, G.A. Delsing, A.B. Roberts, M.B. Sporn, and A.S. Fauci. 1989. Further studies of the role of transforming growth factor-β in human B cell function. J. Immunol. 143:1868-1874.
7. Kehrl, J., A. Roberts, L. Wakefield, S. Jakowlew, M. Sporn, and A. Fauci. 1986. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855-3860.
8. Mule, J., S. Schwarz, A. Roberts, M. Sporn, and S. Rosenberg. 1988. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. 26:95-100.
9. Ranges, G., I. Figari, T. Espevik, and M. Palladino. 1987. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J. Exp. Med. 166:991-998.
10. Wahl, S., N. McCartney-Francis, J. Allen, E. Dougherty, and S. Dougherty. 1991. Macrophage production of TGF-β and regulation by TGF-β. Ann. NY Acad. Sci. 593:188-196.
11. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-β. Nature. 334:260-262.
12. Weiner, H.L., A. Friedman, A. Miller, S.J. Khoury, A. Al-Sabbagh, L. Santos, M. Sayegh, R.B. Nussenblatt, D.E. Trentham, and D.A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809-837.